BODY Stock UPDATES Body Central (BODY) 0.3500 09/12/2014 11:

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Body Central (BODY) 0.3500 $BODY

Body Central Corp. Clarifies That 1-for-10 Reverse Stock Split Anticipated to be Effective for Trading Purposes on Tuesday, September 9
GlobeNewswire - Fri Sep 05, 4:17PM CDT
Body Central Corp. (OTC Pink:BODY) (the "Company" , a multi-channel, specialty retailer offering on trend, quality apparel and accessories at value prices, issued a press release on September 4, 2014 announcing that it is effecting a 1-for-10 reverse stock split of its common stock (the "Reverse Stock Split" , pursuant to which each 10 shares of issued and outstanding common stock and equivalents are being converted into 1 share of common stock. The Company wishes to issue a clarification as to the timing pursuant to which the Reverse Stock Split is being implemented.

Body Central Corp. Announces 1-for-10 Reverse Stock Split; Other Changes to Governance Documents Approved at Special Meeting
GlobeNewswire - Thu Sep 04, 4:14PM CDT
Body Central Corp. (OTC Pink:BODY) (the "Company" , a multi-channel, specialty retailer offering on trend, quality apparel and accessories at value prices, announced that it is effecting a 1-for-10 reverse stock split of its common stock which will be effective as of 5:00 p.m. EDT today, September 4, 2014 (the "Split Effective Time" . At the Split Effective Time, each 10 shares of issued and outstanding common stock and equivalents will be converted into 1 share of common stock. In addition, at and following the Split Effective Time, the common stock will trade under a new CUSIP number 09689U201 although the Company's trading symbol, BODY, will remain unchanged.

Body Central Corp. Responds to Investor Questions
GlobeNewswire - Fri Aug 29, 4:46PM CDT
Body Central Corp. (OTC Pink:BODY) (the "Company" recently filed a press release dated August 14, 2014, communicating the results of operations for the thirteen weeks ended June 28, 2014. Within the communication, investors were offered the opportunity to submit relevant questions to the Company. The questions and answers below reflect responses to a sampling of the questions received.

Body Central Corp. Announces Second Quarter 2014 Financial Results
GlobeNewswire - Thu Aug 14, 4:26PM CDT
Body Central Corp. (OTC - Pink: BODY) (the "Company" today announced financial results for the second quarter of 2014.

Body Central Corp. Appoints Three New Directors
GlobeNewswire - Thu Jul 31, 12:02PM CDT
Body Central Corp. (OTC PINK:BODY) (the "Company" is pleased to announce the expansion of its Board of Directors and the appointment of three new directors effective July 31, 2014. The following individuals have been elected to the Board of Directors and help to round out the Board's expertise in the retail operations, supply chain, e-commerce, and public accounting sectors.

Body Central Common Stock to Move to Over the Counter Market
GlobeNewswire - Wed Jul 09, 9:17AM CDT
Body Central Corp. (Nasdaq:BODY), today announced that trading of the Company's common stock on the NASDAQ Stock Market ("NASDAQ" will be suspended prior to the opening of trading today. The Company anticipates that its common stock will be immediately eligible for quotation on the OTC Pink Marketplace at the opening of trading today under the same symbol ("BODY" . The OTC Pink Marketplace is a market tier operated by OTC Markets Group Inc. for over-the-counter traded companies.

Body Central Corp. Announces $18 Million Private Placement of Subordinated Secured Convertible Notes
GlobeNewswire - Mon Jun 30, 7:57AM CDT
Body Central Corp. (Nasdaq:BODY), today announced that it has completed the previously announced review of financing, transactional and strategic alternatives with the closing of a private placement of $18.0 million in principal amount of its 7.5% subordinated secured convertible notes (the "notes" . Interest on the notes will accrue at 7.5% per annum and each quarterly interest payment will be paid in kind by increasing the principal amount due under the notes unless the Company exercises its option to pay cash interest at a rate of 6.75% per annum. The notes are convertible into shares of the Company's common stock at any time at the option of the holder thereof at a conversion price of $0.35, subject to certain adjustments. All amounts will be due and payable in cash on the third anniversary of the issue date, unless earlier converted. In addition, the Company issued new series of its preferred stock, with nominal value, to the holders of the notes granting the power to vote the shares of common stock underlying the notes as if the notes were converted in full. The terms of the preferred stock will grant three of the investors the ability to each elect one director to the Company's board of directors. The Company plans to seek stockholder approval within 90 days for a reverse stock split.

Stock to Watch: Body Central Down 5.9% (BODY)
Comtex SmarTrend(R) - Fri Jun 27, 12:44PM CDT
Body Central (NASDAQ:BODY) is one of today's worst performing penny stocks, down 5.9% to $0.95 on 1.2x average daily volume. Body Central has traded 529,000 shares thus far today, vs. average volume of 427,000 shares per day. The stock has underperformed the Dow (-5.9% to the Dow's -0.4%) and underperformed the S&P 500 (-5.9% to the S&P's -0.2%) during today's trading.

4 Stocks Under $10 Making Big Moves
at The Street - Fri Jun 13, 5:00AM CDT
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

Hot Stock: Body Central, Shares Gain 20.9% (BODY)
Comtex SmarTrend(R) - Fri Mar 28, 11:40AM CDT
Body Central (NASDAQ:BODY) is one of today's best performing low-priced stocks, up 20.9% to $1.10 on 6.8x average daily volume. Body Central has traded 2.9 million shares thus far today, vs. average volume of 433,000 shares per day. The stock has outperformed the Dow (20.9% to the Dow's 0.7%) and outperformed the S&P 500 (20.9% to the S&P's 0.7%) during today's trading.

Body Central (BODY) Stock Hits 52-Week Low as Sell-Off Continues
at The Street - Thu Mar 27, 2:07PM CDT
Body Central (BODY) hit a 52-week low earlier Thursday, a day after negative results in its year-ending quarter sparked a sell-off.

International Game Technology Cuts Previously Issued Guidance
ACCESSWIRE - Thu Mar 27, 4:05AM CDT
International Game Technology (NYSE: IGT) - For an in-depth report on International Game Technology follow: www.BullTrends.com/stockquote/IGT

Nasdaq stocks posting largest volume increases
AP - Wed Mar 26, 5:04PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:

Why Body Central (BODY) Stock Is Plummeting
at The Street - Wed Mar 26, 9:10AM CDT
Body Central (BODY) shares are plummeting before the bell Wednesday after the company said it was growing more likely it would not be able to continue as a going concern after reporting negative results in its year-ending quarter.

Body Central Corp. Announces Fourth Quarter 2013 Financial Results
GlobeNewswire - Tue Mar 25, 3:30PM CDT
Body Central Corp. (Nasdaq:BODY) today announced financial results for the fourth quarter of 2013.

Body Central Corp. Announces Reporting Date for Fourth Quarter and Fiscal 2013 Financial Results
GlobeNewswire - Mon Mar 24, 3:19PM CDT
Body Central Corp. (Nasdaq:BODY) today announced that it plans to report its fourth quarter and fiscal 2013 financial results on Tuesday, March 25, 2014, after the market close. The Company also plans to hold a conference call to discuss its financial results the same day at 4:30 p.m. ET.

Investors look to Lighten Up on Shares of Body Central, Shares Down 6.5% (BODY)
Comtex SmarTrend(R) - Mon Mar 24, 12:46PM CDT
Body Central (NASDAQ:BODY) is one of today's worst performing low-priced stocks, down 6.5% to $1.87 on 1.1x average daily volume. Body Central has traded 387,000 shares thus far today, vs. average volume of 361,000 shares per day. The stock has underperformed the Dow (-6.5% to the Dow's -0.3%) and underperformed the S&P 500 (-6.5% to the S&P's -0.6%) during today's trading.

Why Body Central Corp (BODY) Is Tanking on Friday
at The Street - Fri Mar 14, 2:44PM CDT
Body Central Corp (BODY) is tanking on Friday after filing a notice with the Securities and Exchange Commission (SEC) explaining it would not be able to complete its 10-K as scheduled.

Stock to Watch: Body Central Down 22.5% (BODY)
Comtex SmarTrend(R) - Fri Mar 14, 10:10AM CDT
Body Central (NASDAQ:BODY) is one of today's worst performing low-priced stocks, down 22.5% to $2.20 on 3.7x average daily volume. Body Central has traded 862,000 shares thus far today, vs. average volume of 230,000 shares per day. The stock has underperformed the Dow (-22.5% to the Dow's -0.1%) and underperformed the S&P 500 (-22.5% to the S&P's -0.1%) during today's trading.

CPP Investment Board Reports Fiscal Third Quarter Performance Results
Marketwire Canada - Fri Feb 14, 8:00AM CST
The CPP Fund ended the third quarter of its 2014 fiscal year on December 31, 2013 with net assets of $201.5 billion, compared to $192.8 billion at the end of the previous quarter. The $8.7 billion increase in assets for the quarter comprised $11.1 billion in net investment income, after operating costs, less $2.4 billion of cash outflows. The CPP Fund routinely receives more CPP contributions than are required to pay benefits during the first part of the calendar year and then remits a portion of those funds for benefit payments in the latter part of the year. The portfolio delivered a gross investment return of 5.9% for the quarter.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 74

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 186

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 193

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Updated Category News Views 218

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 166

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 255

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
BETR's Slide: Investors Face Big Losses, Leadership Shift

Updated Category News Views 129

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

Continue Reading
HiTHIUM Joins Cambridge to Boost Global Energy Storage

Updated Category News Views 372

HiTHIUM and Cambridge's New Energy Venture There's a big splash coming out of Xiamen, folks. HiTHIUM, a heavyweight in the energy storage sector, has decided to team up with the University of Cambridge. They inked a deal aiming to bridge the academic ivory tower with industrial grit, focusing on long-duration energy storage. It was all sealed during the Global Energy...

Continue Reading
LaserAway Expands to 244 Clinics Over 20 Years

Updated Category News Views 203

A Milestone in Aesthetic Dermatology Twenty years, folks. That's a long haul for most businesses, let alone one in the fickle field of aesthetic dermatology. LaserAway, the juggernaut in this arena, has just opened its 244th clinic at 6300 Kingery Hwy in Willowbrook, IL. Nothing to be sneezed at. Imagine running a business, let alone one that's been amping up aesthetic...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 115

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading

Top 5 Most Recently Viewed Articles

BioSig Technologies Updates on Merger and Share Issuance Plans

Updated Category News Views 173

BioSig Technologies Provides Merger Update LOS ANGELES and VANCOUVER, British Columbia — BioSig Technologies, Inc. (NASDAQ: BSGM), recently provided a significant update regarding its merger with Streamex Exchange Corporation. The recent developments aim to clarify the status of the merger and ensure all shareholders are informed. Details of the Merger Finalization The...

Continue Reading
De La Rue plc: Key Information on Recent Trading Activities

Updated Category News Views 138

Overview of Recent Trading Activities De La Rue plc has recently made headlines through significant trading activities that reflect its status as a leading player in the security printing and cash management industry. As a key participant in financial and currency-related services, the company often finds itself at the crossroads of public interest and regulatory...

Continue Reading
Spar Nord's Strong Financial Performance in Q1 2025

Updated Category News Views 373

Spar Nord Reports Positive Q1 2025 Financial Results Profit after tax of DKK 491 million and return on equity of 14.0% Spar Nord has kicked off 2025 with a robust profit after tax of DKK 491 million, demonstrating a notable return on equity of 14.0%. While this performance marks a promising start for the year, it has been influenced by declining interest rates impacting...

Continue Reading
Latest Trends in CEO Confidence and Economic Outlook

Updated Category News Views 260

CEO Confidence Insights for Q4 2025 The Conference Board, in partnership with The Business Council, reported a slight decrease in the CEO Confidence measure, which now stands at 48 in the fourth quarter of 2025. This reflects a one-point drop from 49 during the third quarter. The readings below 50 indicate a dominantly negative sentiment among executives. In total, 130...

Continue Reading
Shift in Options Trading: Is Tesla Gaining Momentum Over Nvidia?

Updated Category News Views 301

Shift in Options Trading Dynamics The S&P 500 experienced a modest increase, climbing by around 20 basis points, while the NASDAQ 100 saw a more substantial rise, soaring by an impressive 80 basis points. A significant contributor to this market movement was none other than Tesla (NASDAQ: TSLA), which experienced a remarkable surge of about 20% in its stock price....

Continue Reading